On the Monocyte panel, odds ratio (OR) of CX3CR1 on monocyte on HCC risk was estimated to be 0.770 (95% CI 0.6589–0.900, P = 1.031 × 10–3) by using IVW approach. Here, CX3CR1 is linked to hepatocellular carcinoma.